List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #33,331 to #33,380.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. MERSCOVMiddle East respiratory syndrome coronavirus infection
  2. MERS COVMiddle East respiratory syndrome coronavirus infection
  3. MERS CoVMiddle East respiratory syndrome coronavirus infection causes#Virology
  4. MERS CoV infectionMiddle East respiratory syndrome coronavirus infection
  5. MERS CovMiddle East respiratory syndrome coronavirus infection
  6. MERS coronavirusMiddle East respiratory syndrome coronavirus infection causes#Virology
  7. MERS covMiddle East respiratory syndrome coronavirus infection
  8. MERS infectionMiddle east respiratory syndrome coronavirus infection
  9. MERS virusMiddle East respiratory syndrome coronavirus infection causes#Virology
  10. METAFERUse Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation
  11. METEORMeasuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
  12. MEXISThe Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
  13. MFPSodium monofluorophosphate
  14. MGAMMaltase-glucoamylase
  15. MGUSMonoclonal gammopathy of undetermined significance
  16. MGluRMetabotropic glutamate receptor
  17. MGluR1Metabotropic glutamate receptor 1
  18. MGluR5Metabotropic glutamate receptor 5
  19. MHMalignant hyperthermia
  20. MHAMicroangiopathic hemolytic anemia
  21. MHC Class IMHC class I
  22. MHC Class IIMHC class II
  23. MHC IMHC class I
  24. MHC IIMHC class II
  25. MHC II DMHLA-DM
  26. MHC II DPHLA-DP
  27. MHC II DQHLA-DQ
  28. MHC II DRHLA-DR
  29. MHFTMunich Mild Heart Failure Trial
  30. MHRAMedicines and Healthcare products Regulatory Agency
  31. MHTHormone replacement therapy (menopause)
  32. MIST elevation myocardial infarction
  33. MIAMIMetoprolol In Acute Myocardial Infarction
  34. MICMinimum inhibitory concentration
  35. MICRO-HOPEMicroalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
  36. MIDCABMinimally invasive direct coronary artery bypass surgery
  37. MILISMultiple Center Investigation Of The Limit Of Infarction
  38. MINTA Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
  39. MIRACLEffects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial
  40. MIRACLE ICDMulticenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
  41. MISME SyndromeNeurofibromatosis type II
  42. MISTMigraine Intervention With Starflex Technology
  43. MITFMicrophthalmia-associated transcription factor
  44. MITI IMyocardial Infarction Triage And Intervention Project--Phase I
  45. MITI IIMyocardial Infarction Triage And Intervention Project--Phase I
  46. MITRAMaximal Individual Therapy In Acute Myocardial Infarction
  47. MITTIntention to treat analysis
  48. MI and pregnancyST elevation myocardial infarction in pregnancy
  49. MI and pregnantST elevation myocardial infarction in pregnancy
  50. MI biomarkersST elevation myocardial infarction diagnostic criteria#Biomarkers in the Diagnosis of MI

View ( | ) (20 | 50 | 100 | 250 | 500)